Description
Buy Authentic Survodutide 10mg Online
Survodutide 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
What Survodutide 10mg is
Survodutide is an investigational dual agonist of the GLP-1 receptor and the glucagon receptor GCGR. It’s also known by the code name BI 456906. The “10mg” refers to lyophilized powder per vial for research use. It’s a peptide designed to mimic effects of both GLP-1 and glucagon to study metabolic regulation. It is not FDA-approved and is sold strictly as a research chemi
Key Product Details Of Survodutide 10mg
- Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
- Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
- Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
- Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
Research Documentation Context
- Supports compound characterization in controlled laboratory settings.
- Provides batch-specific identity and purity documentation for research review.
- Allows lot-level traceability across laboratory documentation workflows.
- Supports comparison of product labeling, analytical documentation, and storage information during research planning.
- Supports analytical review of receptor-pathway research materials within a strictly laboratory-focused context.
Specifications and Documentation
- Certificate of Analysis: Available with batch-specific documentation where applicable.
- Material Safety Data Sheet: Coming Soon.
- Handling and Storage Instructions: Coming Soon.
- Product Form: Lyophilized powder.
- Purity Specification: ≥99% purity.
- Intended Use: Laboratory research use only.
Survodutide 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
How researchers study it
In preclinical and early clinical models, Survodutide is used to investigate energy expenditure, appetite regulation, glucose homeostasis, and liver fat metabolism. GLP-1R activation tends to reduce appetite and slow gastric emptying. GCGR activation tends to increase energy expenditure and hepatic lipid oxidation. The dual approach is being studied in obesity, MASH/NASH, and type 2 diabetes models to see if combining both pathways gives added metabolic benefit beyond GLP-1 alone.
Why it got research attention
Pharma interest in dual incretin/glucagon agonists grew after data showed GLP-1 drugs help with weight and glucose, but adding GCGR activity might further improve liver fat and energy expenditure. Boehringer Ingelheim sponsored Phase 2 trials of Survodutide in obesity and MASH. Published results showed dose-dependent weight loss and reductions in liver fat. It’s part of the same class concept as retatrutide and mazdutide, but with a GLP-1 + glucagon profile instead of GLP-1 + GIP + glucagon.
Form, purity & handling
For research supply, Survodutide 10mg typically comes as a white, freeze-dried powder in a sterile vial. Reputable suppliers should provide a COA with HPLC and mass spec confirming sequence and purity, usually >95% for research grade. Peptides are sensitive to heat, light, and moisture.Store at -20°C or -80°C after reconstitution. The clinical trial formulation is different and not commercially available.
Legal + safety status
Survodutide is not FDA-approved for any indication. It’s classified “for research use only, not for human consumption.” It’s currently in clinical development by Boehringer Ingelheim. No established dosing, no long-term safety data, and no approved clinical use outside trials. As with other GLP-1/GCGR peptides, theoretical risks studied in trials include GI effects, heart rate changes, and liver enzyme changes. Use in research must follow institutional guidelines.
Bottom line
*Survodutide 10mg* is an investigational research peptide used to study dual GLP-1R/GCGR agonism for metabolism and liver disease. Early trial data showed promise for weight loss and MASH, but it has no regulatory approval and no proven clinical benefit yet. *No peptide is a substitute for FDA-approved therapies or evidence-based medical care.* For weight, diabetes, or liver health concerns, talk to a licensed healthcare provider about approved GLP-1 drugs, lifestyle interventions, and therapies with proven clinical data.
